Home > Insider Trading > Filing (0001567619-23-003223)

Filing Details

Accession Number:: 0001567619-23-003223
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-16 18:56:07
Reporting Period:: 2023-02-14

Accepted Time:: 2023-02-16 18:56:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1740719	V Kathy Turner	One Idexx Drive Westbrook ME 04092	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-14	210	$0.00	7,151	No	4	M	Direct
Common Stock	Acquisiton	2023-02-14	181	$0.00	7,332	No	4	M	Direct
Common Stock	Acquisiton	2023-02-14	162	$0.00	7,440	No	4	M	Direct
Common Stock	Acquisiton	2023-02-14	86	$0.00	7,580	No	4	M	Direct
Common Stock	Acquisiton	2023-02-14	93	$0.00	7,673	No	4	M	Direct
Common Stock	Disposition	2023-02-14	293	$503.65	7,380	No	4	F	Direct
Common Stock	Acquisiton	2023-02-14	2,000	$79.54	9,380	No	4	M	Direct
Common Stock	Disposition	2023-02-14	1,000	$505.06	8,380	No	4	S	Direct
Common Stock	Disposition	2023-02-14	313	$504.66	8,067	No	4	S	Direct
Common Stock	Disposition	2023-02-14	577	$504.09	7,490	No	4	S	Direct
Common Stock	Disposition	2023-02-14	110	$502.81	7,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2023-02-14	210	$0.00	210	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-02-14	181	$0.00	181	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-02-14	162	$0.00	162	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-02-14	86	$0.00	86	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-02-14	93	$0.00	93	$0.00
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2023-02-14	2,000	$0.00	2,000	$79.54

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,315		No	4	M	Direct
1,134		No	4	M	Direct
972		No	4	M	Direct
886		No	4	M	Direct
793		No	4	M	Direct
4,736	2025-02-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	100	Indirect	by spouse

Footnotes

Represents the weighted average price of the shares sold ranging from a low of $505.00 to a high of $505.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $504.49 to a high of $504.75 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $503.43 to a high of $504.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $502.42 to a high of $503.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.